Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Incyte Pulls Parsaclisib Files As FDA Takes Foot Off Accelerator
Was Seeking Accelerated Approval For PI3K inhibitor For Lymphoma
Jan 26 2022
•
By
Kevin Grogan
FDA no longer keen on accelerated approval green lights • Source: Alamy
More from Anticancer
More from Therapeutic Category